Checking the plausibility of psychiatrists' arguments for not prescribing depot medication

European Neuropsychopharmacology

Volumn 24, Issue 9, 2014, Pages 1506-1510

  Hamann, Johannes ^a   Kissling, Werner ^a   Heres, Stephan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antipsychotics; Depot treatment; Schizophrenia

Indexed keywords

DEPOT ANTIPSYCHOTIC; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION;

ADULT; ANXIETY; ARTICLE; CLINICAL DECISION MAKING; DOCTOR PATIENT RELATION; FEMALE; HUMAN; INFORMATION DISSEMINATION; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PATIENT INFORMATION; PATIENT PREFERENCE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; PSYCHOPHARMACOTHERAPY; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; TREATMENT REFUSAL; ADOLESCENT; AGED; CLINICAL PRACTICE; DELAYED RELEASE FORMULATION; HEALTH PERSONNEL ATTITUDE; MIDDLE AGED; PSYCHOLOGY; PSYCHOTIC DISORDERS; THERAPEUTIC USE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; ATTITUDE OF HEALTH PERSONNEL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; YOUNG ADULT;

EID: 84907597773     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2014.06.015     Document Type: Article

References (13)

1. Brown J.D., Barrett A., Caffery E., Hourihan K., Ireys H.T. State and demographic variation in use of depot antipsychotics by medicaid beneficiaries with schizophrenia. Psychiatr. Serv. 2014, 65:121-124.
2. Hamann J., Leucht S., Kissling W. Shared decision making in psychiatry. Acta Psychiatr. Scand. 2003, 107:403-409.
3. Hamann J., Lipp M.L., Christ-Zapp S., Spellmann I., Kissling W. Psychiatrist and Patient Responses to Suspected Medication Nonadherence in Schizophrenia Spectrum Disorders. Psychiatr. Serv. 2014, 65:881-887.
4. Heres S., Hamann J., Kissling W., Leucht S. Attitudes of psychiatrists toward antipsychotic depot medication. J. Clin. Psychiatry 2006, 67:1948-1953.
5. Jaeger M., Rossler W. Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists. Psychiatry Res. 2010, 175:58-62.
6. Kane J.M., Kishimoto T., Correll C.U. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies. World Psychiatry 2013, 12:216-226.
7. Kisely S., Ligate L., Roy M.A., Lavery T. Applying Motivational Interviewing to the initiation of long-acting injectable atypical antipsychotics. Australas. Psychiatry 2012, 20:138-142.
8. Lasser R.A., Schooler N.R., Kujawa M., Docherty J., Weiden P. A new psychosocial tool for gaining patient understanding and acceptance of long-acting injectable antipsychotic therapy. Psychiatry 2009, 6:22-27.
9. Leucht C., Heres S., Kane J.M., Kissling W., Davis J.M., Leucht S. Oral versus depot antipsychotic drugs for schizophrenia--a critical systematic review and meta-analysis of randomised long-term trials. Schizophr. Res. 2011, 127:83-92.
10. Patel M.X., Taylor M., David A.S. Antipsychotic long-acting injections: mind the gap. Br. J. Psychiatry Suppl. 2009, 52:S1-4.
11. Tiihonen J., Haukka J., Taylor M., Haddad P.M., Patel M.X., Korhonen P. A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am. J. Psychiatry 2011, 168:603-609.
12. Velligan D.I., Lam Y.W., Glahn D.C., Barrett J.A., Maples N.J., Ereshefsky L., Miller A.L. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr. Bull. 2006, 32:724-742.
13. Weiden P.J., Kozma C., Grogg A., Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr. Serv. 2004, 55:886-891.